2 results match your criteria: "Knight Cancer Institute and Oregon Health Science University[Affiliation]"
Causation of increased prostate cancer in young men.
Oncoscience
March 2021
Departments of Medicine, Pediatrics, and Pathology, McMaster University and McMaster Children's Hospital, Hamilton, Ontario, Canada.
Effect of M1a and M1b category in metastatic colorectal cancer.
Oncologist
July 2014
Division of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Division of Medical Oncology, Juravinski Cancer Centre, McMaster University, Hamilton, Ontario, Canada; Division of Medical Oncology, Knight Cancer Institute and Oregon Health Science University, Portland, Oregon, USA; Breast and Gastrointestinal Cancer Outcomes Unit, Cancer Surveillance & Outcomes, and Cancer Control Research, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
Background: In 2009, the American Joint Committee on Cancer version 7 staging system introduced the M1 subclassifications M1a (single metastatic site) and M1b (peritoneal or multiple metastatic sites). The study objectives were to evaluate the prognostic effect of site of metastasis and M1a/b category among patients with newly diagnosed colorectal cancer and synchronous metastasis.
Patients And Methods: Patients with newly diagnosed pathologic or clinical category M1 colorectal cancer referred to the British Columbia Cancer Agency between 1999 and 2007 were included.